Rona’s Breakthrough: Targeting Heart Disease with RNA Therapy
Company to initiate clinical study of gene-silencing drug targeting hypertriglyceridemia via a reduction in APOC3 protein expression. Chinese biotech Rona … Continue reading "Rona gets FDA go-ahead for Phase 2...
